[Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab].

Ipertensione polmonare pre-capillare o post-capillare? Il ruolo dei test provocativi in sala di emodinamica.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Jul 2022
Historique:
entrez: 30 6 2022
pubmed: 1 7 2022
medline: 6 7 2022
Statut: ppublish

Résumé

The discrimination between heart failure with preserved ejection fraction (HFpEF) and pulmonary arterial hypertension (PAH) requires a multiparametric approach, eventually culminating in right heart catheterization. Solving this differential diagnosis is crucial in order to properly tailor patient treatment, with relevant clinical implications. However, it is not uncommon to be confronted with patients at intermediate or high risk of having HFpEF whose pulmonary artery wedge pressure (PAWP) falls in a grey zone in between 13 and 15 mmHg. In these patients, a provocative test in the cath lab might be considered, with the aim of unmasking an occult form of HFpEF with non-overt hemodynamic manifestations, or to definitely exclude it.Saline load and physical exercise can be viewed as the most suitable provocative tests seeking to help for the differential diagnosis in this specific patient population. Although normative values for the hemodynamic response to these maneuvers have been proposed, supporting evidence is still preliminary or equivocal. In this paper, we will review the pathophysiological background for the application of provocative tests in the cath lab, as well as methodological and interpretative aspects to discriminate between HFpEF and PAH, highlighting strengths and weaknesses of fluid load and physical exercise.

Identifiants

pubmed: 35771019
doi: 10.1714/3831.38171
doi:

Types de publication

Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

533-541

Auteurs

Sergio Caravita (S)

Centro per la Dispnea e l'Ipertensione Polmonare, Dipartimento di Cardiologia, Istituto Auxologico Italiano IRCCS Ospedale San Luca, Milano - Dipartimento di Ingegneria Gestionale, dell'Informazione e della Produzione, Università degli Studi di Bergamo, Dalmine (BG).

Claudio Picariello (C)

U.O.C. Cardiologia, Azienda ULSS 5 Polesana, Ospedale "Santa Maria della Misericordia", Rovigo.

Andrea Garascia (A)

Dipartimento Cardiotoracovascolare "A. De Gasperis", ASST Grande Ospedale Metropolitano Niguarda, Milano.

Leonardo Misuraca (L)

U.O.S.D. Cardiologia Interventistica, Ospedale della Misericordia, Grosseto.

Elisabetta De Tommasi (E)

U.O.C. Cardiologia Ospedaliera, Policlinico di Bari.

Egidio Imbalzano (E)

Dipartimento di Medicina Interna e Terapia Medica, Università degli Studi, Messina.

Iolanda Enea (I)

U.O.C. Medicina e Chirurgia d'Urgenza, A.O.R.N. "S. Anna e S. Sebastiano", Caserta.

Loris Roncon (L)

U.O.C. Cardiologia, Azienda ULSS 5 Polesana, Ospedale "Santa Maria della Misericordia", Rovigo.

Marco Vatrano (M)

U.O.C. Cardiologia, Azienda Ospedaliera "Pugliese-Ciaccio", Catanzaro.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH